Rilematovir

JNJ-678 is a novel inhibitor of the fusion protein. JNJ-678 shows the potential for respiratory syncytial virus (RSV) treatment.

1383450-81-4

≥ 2 years

>98% (HPLC)

500.92

C21H20ClF3N4O3S

Research use only, not for human use.

——

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

27879-01 250 mL

Ask

27879-02 1000 mL

Ask

FAB1481JF525 0.5 mL

Ask

CRP1185-01 10 µg

Ask

CRP1185-02 50 µg

Ask

CRP1185-03 500 µg

Ask